뜰
뜰's KOBDi Score is 40.19 as of Sep 2026, up 11.72 points since Apr 2025; it rose in 5 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 51% of companies in its industry, against 51% in Aug 2026 and 39% in Apr 2025. Its strongest position was 51% (Sep 2026) and its weakest 38% (Aug 2025).
A year earlier, in Aug 2025, its score was 28.63 and it was ahead of about 38% of companies in its industry.
| Sep 2026 | 40.19 | ahead of 51% |
| Aug 2026 | 40.18 | ahead of 51% |
| Jul 2026 | 40.02 | ahead of 51% |
| Jun 2026 | 30.08 | ahead of 42% |
| May 2026 | 30.08 | ahead of 42% |
| Apr 2026 | 30.08 | ahead of 42% |
| Mar 2026 | 30.08 | ahead of 43% |
| Feb 2026 | 30.08 | ahead of 43% |
| Dec 2025 | 30.08 | ahead of 43% |
| Aug 2025 | 28.63 | ahead of 38% |
| Jul 2025 | 28.47 | ahead of 39% |
| May 2025 | 28.47 | ahead of 40% |
| Apr 2025 | 28.47 | ahead of 39% |
Where is 뜰 located?
뜰 is registered at 전라남도 화순군 화순읍 만연로, South Korea (postal code 58124).
What industry is 뜰 in?
뜰 belongs to Wholesale & Retail Trade › Wholesale – Household Goods & Appliances › Pharmaceutical wholesaler.
How many employees does 뜰 have?
뜰 has 10–19 employees.
What is 뜰's KOBDi Score?
40.19 as of September 2026, ahead of about 51% of companies in its industry.
Who are 뜰's competitors?
Similar companies include SEOUL pharma, 팜에드 and Mediforum.

